By Kristen Honey, PhD, PMP & Daniel Desautels – The U.S. Department of Health and Human Services and the Steven & Alexandra Cohen Foundation announced that the LymeX Diagnostics Prize exit disclaimer icon received 52 Phase 1 submissions.
The second largest federally funded research program at Indiana University School of Medicine will receive $48.8 million over the next five years, fueling the work of researchers as they seek to discover treatments for Alzheimer’s disease.
This week’s Friday Five highlights five episodes you can find right here on HealthcareNOW Radio that focus on disruption and innovation in healthcare. From the Incrementalist, Healthcare IT Today, Healthcare Rap, The Healthcare Leadership Experience, and Voices of Self-Funding, the following shows shine a spotlight on innovation happening NOW.
By Janet Woodcock MD & Meredith Chuk MD – The U.S. Food and Drug Administration’s responsibilities to protect the public health are broad, complex, and necessary because the products we regulate are in every home and used every day across the U.S.
SimX has launched a virtual reality (VR) curriculum of essential EMS training scenarios designed to prepare front line care professionals to provide critical care and avoid errors in emergency situations.
By Cindy Brach MPP – “Research clearly shows that when patients communicate effectively with their healthcare team, clinical care and outcomes improve,” AHRQ Acting Director David Meyers recently noted. Everyone—no matter how educated—appreciates and can benefit from clear communication.
There is no arguing the fact that the coronavirus pandemic impacted and changed lives across the globe. This week’s Friday Five takes a look at some of the innovative products that were created to help us adapt to our new normal and keep ourselves safe.
By Peter Marks MD – The U.S. Food and Drug Administration continues to facilitate the development and availability of innovative medical products, such as regenerative medicine therapies, that have the potential to treat or even cure diseases or conditions for which few effective treatment options exist.
By RADM Denise Hinton & Tina Morrison PhD – We live in an era of rapidly changing technological advancements that enable science to evolve at an unprecedented pace. At the U.S. Food and Drug Administration, we rely on our scientific and technical experts to make sound, science- and evidence-based regulatory decisions to protect and promote public health.